In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...

New study leverages Precision's Layer 7 Cortical Interface for high-resolution brain mapping during craniotomy procedures NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation ...

Brain-computer interface startups are surging — and poised to expand technologically and geographically. After early ...

Doctors conduct the clinical trial of the invasive brain-computer interface in East China's Shanghai, March 25, 2025. [Photo/CEBSIT at CAS/Handout via Xinhua] SHANGHAI -- A Chinese man who lost all ...

Brain computer interface (BCI) developer Paradromics has been cleared by the FDA to start a clinical trial of its Connexus implant that will test how well it can convert thoughts into speech. Austin, ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain data transfer company, today announced that the National Institutes of Health (NIH) has awarded a $10M grant for the initiation of the COMMAND U.S.

California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...

Chinese researchers are planning a major clinical trial next year on technology linking the brain directly with electronic devices, according to a report on a Shanghai government social media account.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Layer 7 Cortical Interface — a high-resolution cortical electrode array for use in recording, monitoring, and stimulating ...

China’s first clinical trial of a technology that allows signals from the brain to control an external device has shown early signs of success, making it only the second country after the US to reach ...

Cognixion has announced a clinical trial that integrates its non-invasive EEG-based brain–computer interface (BCI) technology with the Apple Vision Pro with no surgery required. The aim of the trial ...